Hyperuricemia and the problem of chronic kidney disease

Hyperuricemia and the problem of chronic kidney disease

The paper reviews the literature on the role of hyperuricemia as a risk factor for chronic kidney disease and as one of the factors for the progression of existing kidney disease. It gives epidemiological information on a relationship between hyperuricemia and kidney lesion. The mechanisms for the d...

Full description

Bibliographic Details
Main Authors:	A V Shcherbak, L V Kozlovskaia, I N Bobkova, I M Balkarov, M V Lebedeva, T Iu Stakhova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-06-01
Series:	Терапевтический архив
Subjects:	hyperuricemia gout chronic kidney disease tubulointerstitial fibrosis epithelial-mesenchymal transdifferentiation
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31327

Similar Items

Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (Β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders
by: T Iu Stakhova, et al.
Published: (2014-06-01)

Hyperuricemia and prognosis in chronic kidney disease
by: D.D. Ivanov, et al.
Published: (2017-08-01)

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
by: Benjamin Rohn, et al.
Published: (2020-01-01)

Prevalence of Hyperuricemia among People of Morang District of Nepal
by: Shrawan Kumar Yadav, et al.
Published: (2015-03-01)

Prevalence of Hyperuricemia among People of Morang District of Nepal
by: Shrawan Kumar Yadav, et al.
Published: (2014-03-01)

UMOD gene mutations in Chinese patients with autosomal dominant tubulointerstitial kidney disease: a pediatric case report and literature review
by: Jing Yang, et al.
Published: (2019-05-01)

FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01)

Hyperuricemia — an independent factor for the progression of chronic kidney disease
by: M.D. Tronko, et al.
Published: (2017-04-01)

Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
by: Tao Han Lee, et al.
Published: (2021-09-01)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017-09-01)

EFFECTIVENESS OF CANEPHRON® N IN THE COMPLEX MANAGEMENT OF SUBCLINICAL GOUTY NEPHROPATHY
by: S. I. Smiyan, et al.
Published: (2016-05-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

A Chronic Untreated Tophaceous Gout with Dilated Cardiomyopathy and Chronic Kidney Disease: A Rare Case Report
by: Soma Srinivas Vejendla, et al.
Published: (2023-07-01)

Asymptomatic hyperuricemia: secret relationships, invisible effects and potential complications
by: I. Yu. Golovach, et al.
Published: (2021-01-01)

Association between hyperuricemia and hypertension in chronic kidney disease
by: QIAN Ying, MA Xiaobo, GAO Chenni, ZHANG Chunli, MA Jun, ZHANG Wen, CHEN Xiaonong
Published: (2023-04-01)

Effectiveness and safety of the herbal preparation Soveren® in patients with hyperuricemia
by: Margarita A. Gromova, et al.
Published: (2023-05-01)

Effects of hyperuricemia on the skin
by: Agnieszka Owczarczyk-Saczonek, et al.
Published: (2017-03-01)

Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria
by: Oluseyi A Adejumo, et al.
Published: (2016-01-01)

Renal affection in gout
by: Il'ya Vadimovich Egorov, et al.
Published: (2012-01-01)

Hyperuricemia and dementia – a case-control study
by: Bettina Engel, et al.
Published: (2018-08-01)

Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice
by: V V Fomin, et al.
Published: (2019-12-01)

Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
by: Nashwa Ismail Hashaad, et al.
Published: (2022-10-01)

Comment on: “Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta‐analysis based on latest evidence”
by: Zain Ali Nadeem, et al.
Published: (2024-02-01)

Hyperuricemia: Features of the Diet
by: O. B. Shvabskaia, et al.
Published: (2022-01-01)

Hyperuricemia as a component of cardiorenal syndrome
by: Nikolay Alekseevich Mukhin, et al.
Published: (2011-06-01)

The Pattern of Allopurinol Prescription Among Chronic Kidney Disease Patients in a Tertiary Care Centre: A Single-Centre Experience
by: Alobaidi S, et al.
Published: (2021-03-01)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
by: Xinghong Wu, et al.
Published: (2023-01-01)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia
by: S V Nedogoda, et al.
Published: (2012-12-01)

Progress in Understanding the Mechanism by Which Probiotics Alletivate Hyperuricemia
by: HUANG Jiahao, LI Xianping, ZHAO Junying, QIAO Weicang, LIU Lu, CHEN Lijun
Published: (2023-12-01)

Hyperuricemia – A narrative review
by: Chieh Chen
Published: (2022-01-01)

Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout
by: Han Qi, et al.
Published: (2023-12-01)

Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01)

Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
by: Yannan Zhang, et al.
Published: (2018-06-01)

The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
by: Xin-yu Fang, et al.
Published: (2022-06-01)

Altered Serum Uric Acid Levels in Kidney Disorders
by: Gheun-Ho Kim, et al.
Published: (2022-11-01)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
by: Robert Eckenstaler, et al.
Published: (2021-06-01)

A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review
by: Ziqiang Lin, et al.
Published: (2018-10-01)

GOUT AND HYPERURICEMIA AS ADDITIONAL FACTORS OF DETERIORATION OF CARDIAC AND RENAL PATHOLOGIES
by: Snigurska I. O., et al.
Published: (2022-11-01)

Hyperuricemia and Hypertension: Links and Risks
by: Stewart DJ, et al.
Published: (2019-12-01)

Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
by: Masataka Honda, et al.
Published: (2021-12-01)